Showing results (111-120 of 324) with videos related to

Sort By:
Pageof 33
Biochemical and Biophysical Research Communications|January 16, 1989
Conformation of high molecular weight kininogen: effects of kallikrein and factor XIa cleavageG B Villanueva, L Leung, H Bradford, et al.
Thrombosis Et Diathesis Haemorrhagica|September 30, 1974
Hemostatic defect due to acquired circulating inhibitors against lipid procoagulant and factor VIIIL Pechet, L M Snyder, C Chesney, et al.
Blood|October 1, 1987
A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surfaceD Veloso, L D Silver, S Hahn, et al.
Thrombosis and Haemostasis|April 2, 1992
Bacterial expression of biologically active high molecular weight kininogen light chainS P Kunapuli, R A DeLa Cadena, R W Colman
Thrombosis Research|November 1, 1993
Specificity of the sequence in Phe-Gln-Val-Val-Cys (-3-nitro-2-pyridinesulfenyl)-Gly-NH2--a selective inhibitor of thrombin-induced platelet aggregationR N Puri, R Matsueda, H Umeyama, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1984
Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian speciesA H Schmaier, E Gustafson, S Idell, et al.
Blood|February 1, 1988
Factor V is activated and cleaved by platelet calpain: comparison with thrombin proteolysisH N Bradford, A Annamalai, K Doshi, et al.
Archives of Biochemistry and Biophysics|November 25, 1998
Partial characterization of the active site human platelet cAMP phosphodiesterase, PDE3A, by site-directed mutagenesisP P Cheung, L Yu, H Zhang, et al.
Blood|July 10, 1998
Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filtersC F Scott, H Brandwein, J Whitbread, et al.
Blood|August 1, 1976
Potassium uptake and release by human blood plateletsJ S Wiley, J Kuchibhotla, C C Shaller, et al.
Pageof 33